• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

白细胞介素1β(IL1B)(-511)、白细胞介素1β(IL1B)(+3954)、白细胞介素1受体拮抗剂(IL1RN)(可变数目串联重复序列,VNTR)基因多态性与格雷夫斯病风险之间的关联:11项病例对照研究的荟萃分析

Association between the IL1B (-511), IL1B (+3954), IL1RN (VNTR) polymorphisms and Graves' disease risk: a meta-analysis of 11 case-control studies.

作者信息

Chen Min-Li, Liao Ning, Zhao Hua, Huang Jian, Xie Zheng-Fu

机构信息

Department of Geriatrics and Gerontology, First Affiliated Hospital, Guangxi Medical University, Nanning, China.

Department of Clinical Medicine, Grade 2001, Guangxi Medical University, Nanning, China.

出版信息

PLoS One. 2014 Jan 21;9(1):e86077. doi: 10.1371/journal.pone.0086077. eCollection 2014.

DOI:10.1371/journal.pone.0086077
PMID:24465880
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3897612/
Abstract

BACKGROUND

Data on the association between the interleukin-1 (IL-1) gene polymorphisms and Graves' disease (GD) risk were conflicting. A meta-analysis was undertaken to assess this association.

METHODS

We searched for case-control studies investigating the association between the IL1B (-511), IL1B (+3954), IL1RN (VNTR) polymorphisms and GD risk. We extracted data using standardized forms and calculated odds ratios (OR) with 95% confidence intervals (CI).

RESULTS

A total of 11 case-control studies were included in this meta-analysis. Available data indicated that the IL1B (-511) polymorphism was associated with GD risk in the overall populations (Caucasians and Asians) in homozygote model (TT vs. CC, OR = 0.86, 95% CI: 0.76-0.97, Pz  = 0.015), but not in dominant and recessive models (TT+TC vs. CC: OR = 0.95, 95% CI: 0.81-1.12, Pz  =  0.553 and TT vs. TC+CC: OR = 0.82, 95% CI: 0.60-1.12, Pz  =  0.205, respectively). No association between the IL1B (+3954), IL1RN (VNTR) polymorphisms and GD risk was found in the overall populations in any of the genetic models. In subgroup analyses according to ethnicity, the IL1B (-511) polymorphism was associated with GD risk in Asians in recessive and homozygote models (TT vs. TC+CC: OR =  0.68, 95% CI: 0.55-0.84, Pz < 0.001 and TT vs. CC: OR = 0.81, 95% CI: 0.70-0.93, Pz  =  0.003, respectively), but not in dominant model (TT+TC vs. CC: OR =  0.92, 95% CI: 0.77-1.11, Pz  =  0.389). No association between the IL1B (+3954), IL1RN (VNTR) polymorphisms and GD risk was indicated in Asians, and we found no association between the IL1B (-511), IL1B (+3954), IL1RN (VNTR) polymorphisms and GD risk in Caucasians in any of the genetic models.

CONCLUSION

The IL1B (-511) polymorphism, but not the IL1B (+3954) and IL1RN (VNTR) polymorphisms was associated with GD risk in Asians. There was no association between these polymorphisms and GD risk in Caucasians.

摘要

背景

白细胞介素 -1(IL-1)基因多态性与格雷夫斯病(GD)风险之间的关联数据存在冲突。进行了一项荟萃分析以评估这种关联。

方法

我们检索了调查IL1B(-511)、IL1B(+3954)、IL1RN(VNTR)多态性与GD风险之间关联的病例对照研究。我们使用标准化表格提取数据,并计算了比值比(OR)及95%置信区间(CI)。

结果

本荟萃分析共纳入11项病例对照研究。现有数据表明,在纯合子模型中,IL1B(-511)多态性与总体人群(白种人和亚洲人)的GD风险相关(TT与CC相比,OR = 0.86,95%CI:0.76 - 0.97,P = 0.015),但在显性和隐性模型中不相关(TT + TC与CC相比:OR = 0.95,95%CI:0.81 - 1.12,P = 0.553;TT与TC + CC相比:OR = 0.82,95%CI:0.60 - 1.12,P = 0.205)。在任何遗传模型中,总体人群中均未发现IL1B(+3954)、IL1RN(VNTR)多态性与GD风险之间存在关联。在按种族进行的亚组分析中,IL1B(-511)多态性在隐性和纯合子模型中与亚洲人的GD风险相关(TT与TC + CC相比:OR = 0.68,95%CI:0.55 - 0.84,P < 0.001;TT与CC相比:OR = 0.81,95%CI:0.70 - 0.93,P = 0.003),但在显性模型中不相关(TT + TC与CC相比:OR = 0.92,95%CI:0.77 - 1.11,P = 0.389)。亚洲人中未发现IL1B(+3954)、IL1RN(VNTR)多态性与GD风险之间存在关联;在任何遗传模型中,白种人中IL1B(-511)、IL1B(+3954)、IL1RN(VNTR)多态性与GD风险之间均无关联。

结论

IL1B(-511)多态性与亚洲人的GD风险相关,而IL1B(+3954)和IL1RN(VNTR)多态性与亚洲人的GD风险无关。这些多态性与白种人的GD风险之间无关联。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0d47/3897612/917caf86a4b1/pone.0086077.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0d47/3897612/e5ab95f9f4c1/pone.0086077.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0d47/3897612/4631694b860a/pone.0086077.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0d47/3897612/917caf86a4b1/pone.0086077.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0d47/3897612/e5ab95f9f4c1/pone.0086077.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0d47/3897612/4631694b860a/pone.0086077.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0d47/3897612/917caf86a4b1/pone.0086077.g003.jpg

相似文献

1
Association between the IL1B (-511), IL1B (+3954), IL1RN (VNTR) polymorphisms and Graves' disease risk: a meta-analysis of 11 case-control studies.白细胞介素1β(IL1B)(-511)、白细胞介素1β(IL1B)(+3954)、白细胞介素1受体拮抗剂(IL1RN)(可变数目串联重复序列,VNTR)基因多态性与格雷夫斯病风险之间的关联:11项病例对照研究的荟萃分析
PLoS One. 2014 Jan 21;9(1):e86077. doi: 10.1371/journal.pone.0086077. eCollection 2014.
2
Lack of Association Between the IL1B (-511 and +3954), IL1RN VNTR Polymorphisms and Tuberculosis Risk: A Meta-analysis.白细胞介素 1B(-511 和+3954)、白细胞介素 1 受体拮抗剂 VNTR 多态性与结核病易感性的关联研究:荟萃分析。
Lung. 2015 Dec;193(6):985-92. doi: 10.1007/s00408-015-9796-5. Epub 2015 Sep 2.
3
Association between the IL1B, IL1RN polymorphisms and COPD risk: a meta-analysis.白细胞介素1β(IL1B)、白细胞介素1受体拮抗剂(IL1RN)基因多态性与慢性阻塞性肺疾病(COPD)风险的关联:一项荟萃分析
Sci Rep. 2014 Sep 1;4:6202. doi: 10.1038/srep06202.
4
Lack of association between the IL-13 C-1112T, G2044A polymorphisms and Graves' disease risk: evidence from a meta-analysis.白细胞介素-13基因C-1112T、G2044A多态性与格雷夫斯病风险之间无关联:一项荟萃分析的证据
Immunol Invest. 2014;43(4):337-48. doi: 10.3109/08820139.2013.879170. Epub 2014 Feb 24.
5
IL1B -511(G>A) and IL1RN (VNTR) allelic polymorphisms and susceptibility to knee osteoarthritis in Croatian population.IL1B-511(G>A) 和 IL1RN(VNTR) 等位基因多态性与克罗地亚人群膝骨关节炎易感性的关系。
Rheumatol Int. 2012 Jul;32(7):2135-41. doi: 10.1007/s00296-011-1946-3. Epub 2011 Apr 27.
6
Association of polymorphic variants of IL-1β and IL-1RN genes in the development of Graves' disease in Kashmiri population (North India).印度北部克什米尔人群中白细胞介素-1β(IL-1β)和白细胞介素-1受体拮抗剂(IL-1RN)基因多态性变异与格雷夫斯病发生的关联
Hum Immunol. 2018 Apr;79(4):228-232. doi: 10.1016/j.humimm.2018.02.006. Epub 2018 Feb 14.
7
Interleukin-1beta and interleukin-1 receptor antagonist gene polymorphisms and gastric cancer: a meta-analysis.白细胞介素-1β和白细胞介素-1受体拮抗剂基因多态性与胃癌:一项荟萃分析。
Cancer Epidemiol Biomarkers Prev. 2006 Sep;15(9):1674-87. doi: 10.1158/1055-9965.EPI-06-0189.
8
Association of polymorphisms of rs179247 and rs12101255 in thyroid stimulating hormone receptor intron 1 with an increased risk of Graves' disease: A meta-analysis.促甲状腺激素受体内含子1中rs179247和rs12101255多态性与格雷夫斯病风险增加的关联:一项荟萃分析。
J Huazhong Univ Sci Technolog Med Sci. 2016 Aug;36(4):473-479. doi: 10.1007/s11596-016-1611-x. Epub 2016 Jul 28.
9
Interleukin-1B and interleukin-1 RN polymorphisms and gastric carcinoma risk: a meta-analysis.白细胞介素-1β和白细胞介素-1受体拮抗剂基因多态性与胃癌风险:一项荟萃分析。
J Gastroenterol Hepatol. 2010 Oct;25(10):1604-17. doi: 10.1111/j.1440-1746.2010.06428.x.
10
The association between IL-1 family gene polymorphisms and colorectal cancer: A meta-analysis.白细胞介素-1家族基因多态性与结直肠癌的关联:一项荟萃分析。
Gene. 2021 Feb 15;769:145187. doi: 10.1016/j.gene.2020.145187. Epub 2020 Sep 28.

引用本文的文献

1
Programmed Cell Death in the Small Intestine: Implications for the Pathogenesis of Celiac Disease.小肠中的程序性细胞死亡:对乳糜泻发病机制的影响。
Int J Mol Sci. 2021 Jul 10;22(14):7426. doi: 10.3390/ijms22147426.
2
and cytokine gene variants as predictors of premalignant gastric lesions.以及细胞因子基因变异作为癌前胃病变预测因子。
World J Gastroenterol. 2019 Aug 14;25(30):4105-4124. doi: 10.3748/wjg.v25.i30.4105.
3
Expression levels and genetic polymorphisms of interleukin-2 and interleukin-10 as biomarkers of Graves' disease.

本文引用的文献

1
Localized myxedema of thyroid disease.甲状腺疾病的局限性黏液性水肿
J Am Acad Dermatol. 2013 Jun;68(6):e189-90. doi: 10.1016/j.jaad.2012.11.019.
2
Association between age at diagnosis of Graves' disease and variants in genes involved in immune response.格雷夫斯病诊断年龄与免疫反应相关基因变异的关联。
PLoS One. 2013;8(3):e59349. doi: 10.1371/journal.pone.0059349. Epub 2013 Mar 27.
3
Association of the IL1RN gene VNTR polymorphism with human male infertility.白细胞介素 1 受体拮抗剂基因 VNTR 多态性与男性不育的相关性研究。
白细胞介素-2和白细胞介素-10的表达水平及基因多态性作为格雷夫斯病的生物标志物
Exp Ther Med. 2015 Mar;9(3):925-930. doi: 10.3892/etm.2015.2180. Epub 2015 Jan 14.
4
Allele-specific induction of IL-1β expression by C/EBPβ and PU.1 contributes to increased tuberculosis susceptibility.C/EBPβ和PU.1对IL-1β表达的等位基因特异性诱导作用导致结核病易感性增加。
PLoS Pathog. 2014 Oct 16;10(10):e1004426. doi: 10.1371/journal.ppat.1004426. eCollection 2014 Oct.
PLoS One. 2012;7(12):e51899. doi: 10.1371/journal.pone.0051899. Epub 2012 Dec 14.
4
Single nucleotide polymorphisms in IL1B and the risk of acute coronary syndrome: a Danish case-cohort study.IL1B 单核苷酸多态性与急性冠状动脉综合征风险:丹麦病例-队列研究。
PLoS One. 2012;7(6):e36829. doi: 10.1371/journal.pone.0036829. Epub 2012 Jun 29.
5
Palmitate induced secretion of IL-6 and MCP-1 in orbital fibroblasts derived from patients with thyroid-associated ophthalmopathy.棕榈酸酯诱导甲状腺相关眼病患者来源的眼眶成纤维细胞分泌白细胞介素-6和单核细胞趋化蛋白-1。
Mol Vis. 2012;18:1467-77. Epub 2012 Jun 4.
6
Quercetin inhibits IL-1β-induced inflammation, hyaluronan production and adipogenesis in orbital fibroblasts from Graves' orbitopathy.槲皮素抑制格雷夫斯眼病眼眶成纤维细胞中 IL-1β 诱导的炎症、透明质酸产生和脂肪生成。
PLoS One. 2011;6(10):e26261. doi: 10.1371/journal.pone.0026261. Epub 2011 Oct 19.
7
Association between circulating interleukin-1 beta (IL-1β) levels and IL-1β C-511T polymorphism with cervical cancer risk in Egyptian women.循环白细胞介素-1β(IL-1β)水平与 IL-1β C-511T 多态性与埃及女性宫颈癌风险的关系。
Mol Cell Biochem. 2011 Jul;353(1-2):159-65. doi: 10.1007/s11010-011-0782-9. Epub 2011 Mar 23.
8
Association of interleukin-1beta (IL1B) polymorphisms with Graves' ophthalmopathy in Taiwan Chinese patients.白细胞介素-1β(IL1B)多态性与台湾汉族 Graves 眼病的相关性。
Invest Ophthalmol Vis Sci. 2010 Dec;51(12):6238-46. doi: 10.1167/iovs.09-4965. Epub 2010 Jul 29.
9
Genetic susceptibility to autoimmune thyroid disease: past, present, and future.自身免疫性甲状腺疾病的遗传易感性:过去、现在和未来。
Thyroid. 2010 Jul;20(7):715-25. doi: 10.1089/thy.2010.1644.
10
The interleukin-1 family gene polymorphisms and Graves' disease.白细胞介素-1 家族基因多态性与 Graves 病。
Ann Endocrinol (Paris). 2010 Sep;71(4):281-5. doi: 10.1016/j.ando.2010.01.005. Epub 2010 Apr 18.